Clinical Rheumatology

, Volume 37, Issue 7, pp 1913–1920 | Cite as

The outcomes and risk factors of early readmission in patients with intestinal Behçet’s disease

  • Yong Eun Park
  • Jae Hee CheonEmail author
  • Yehyun Park
  • Soo Jung Park
  • Tae Il Kim
  • Won Ho Kim
Original Article


Hospital readmission rate is an integral quality of care measurement for hospitalized patients which is unknown for intestinal Behçet’s disease cases. The purpose of this study was to investigate the risk factors and outcomes for patients readmitted early with intestinal Behçet’s disease. We retrospectively reviewed patients with intestinal Behçet’s disease who were readmitted to our hospital between 2005 and 2016. We then analyzed the risk factors and outcomes for early readmission within 3 months. Of the 204 patients who were readmitted, 103 patients (50.5%) were readmitted within 3 months and 101 (49.5%) were never readmitted or readmitted after 3 months. After multivariate analysis, hospital stay at the first admission (adjusted odds ratio [OR], 0.945; 95% confidence interval [CI], 0.908–0.982; P = 0.004), high disease activity index for intestinal Behçet’s disease score (adjusted OR, 1.111; 95% CI, 1.060–1.165; P < 0.001), corticosteroid use (adjusted OR, 3.179; 95% CI, 1.135–8.910; P = 0.028), and opioid use (adjusted OR, 7.979; 95% CI, 1.084–58.755; P = 0.041) were independent factors for early readmission. We identified four independent prognostic factors for early readmission within 3 months, which might help guide appropriate management strategies for hospitalized patients with intestinal Behçet’s disease.


Intestinal Behçet’s disease Prognostic factor Readmission 



Behçet’s disease




Inflammatory bowel disease


Crohn’s disease


Ulcerative colitis


Disease activity index for intestinal Behçet’s disease


Erythrocyte sedimentation rate


C-reactive protein


5-Aminosalicylic acid




Nonsteroidal anti-inflammatory drugs


Interquartile range


Odds ratios


Confidence intervals



The authors are grateful to Dong-Su Jang, (medical illustrator, Medical Research Support Section, Yonsei University College of Medicine, Seoul, Republic of Korea) for his help with the figures.

Guarantor of the article

Jae Hee Cheon.

Author contributions

Yong Eun Park: acquisition of data, analysis and interpretation of data, drafting of the manuscript. Yehyun Park: study concept and design, critical revision of the manuscript for important intellectual content. Soo Jung Park: study concept and design, critical revision of the manuscript for important intellectual content. Tae Il Kim: study concept and design, critical revision of the manuscript for important intellectual content. Won Ho Kim: study concept and design, critical revision of the manuscript for important intellectual content. Jae Hee Cheon: acquisition of data, study concept and design, critical revision of the manuscript for important intellectual content. All authors approved the final version of the article, including the authorship list.

Funding information

This research was supported by a grant (A120176) from the Korean Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), which is funded by the Ministry of Health and Welfare, Republic of Korea; a grant (NRF-2017R1A1A1A05001011) from the Basic Science Research Program through the National Research Foundation of Korea, which is funded by the Ministry of Science, ICT and Future Planning; and a faculty research grant (2012-31-0477) from the Department of Internal Medicine, Yonsei University, College of Medicine.

Compliance with ethical standards

This study was performed in accordance with the ethical guidelines of the 1975 Declaration of Helsinki and approved by the Institutional Review Board of Severance Hospital.



Supplementary material

10067_2017_3904_MOESM1_ESM.docx (31 kb)
ESM 1 (DOCX 30 kb)


  1. 1.
    Cheon JH, Kim WH (2015) An update on the diagnosis, treatment, and prognosis of intestinal Behcet’s disease. Curr Opin Rheumatol 27(1):24–31CrossRefPubMedGoogle Scholar
  2. 2.
    Kim DH, Cheon JH (2016) Intestinal Behcet’s disease: a true inflammatory bowel disease or merely an intestinal complication of systemic vasculitis? Yonsei Med J 57(1):22–32CrossRefPubMedGoogle Scholar
  3. 3.
    Cheon JH, Kim ES, Shin SJ, Kim TI, Lee KM, Kim SW, Kim JS, Kim YS, Choi CH, Ye BD, Yang SK, Choi EH, Kim WH (2009) Development and validation of novel diagnostic criteria for intestinal Behcet’s disease in Korean patients with ileocolonic ulcers. Am J Gastroenterol 104(10):2492–2499CrossRefPubMedGoogle Scholar
  4. 4.
    Cheon JH, Shin SJ, Kim SW, Lee KM, Kim JS, Kim WH (2009) Diagnosis of intestinal Behcet’s disease. Korean J Gastroenterol 53(3):187–193PubMedGoogle Scholar
  5. 5.
    Bayraktar Y, Ozaslan E, Van Thiel DH (2000) Gastrointestinal manifestations of Behcet’s disease. J Clin Gastroenterol 30(2):144–154CrossRefPubMedGoogle Scholar
  6. 6.
    Yi SW, Cheon JH, Kim JH, Lee SK, Kim TI, Lee YC, Kim WH (2009) The prevalence and clinical characteristics of esophageal involvement in patients with Behcet’s disease: a single center experience in Korea. J Korean Med Sci 24(1):52–56CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Park JJ, Kim WH, Cheon JH (2013) Outcome predictors for intestinal Behcet’s disease. Yonsei Med J 54(5):1084–1090CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Tinsley A, Naymagon S, Mathers B, Kingsley M, Sands BE, Ullman TA (2015) Early readmission in patients hospitalized for ulcerative colitis: incidence and risk factors. Scand J Gastroenterol 50(9):1103–1109CrossRefPubMedGoogle Scholar
  9. 9.
    Poojary P, Saha A, Chauhan K, Simoes P, Sands BE, Cho J, Ullman T, Nadkarni G, Ungaro R (2017) Predictors of hospital readmissions for ulcerative colitis in the United States: a national database study. Inflamm Bowel Dis 23(3):347–356PubMedPubMedCentralGoogle Scholar
  10. 10.
    Nguyen GC, Bollegala N, Chong CA (2014) Factors associated with readmissions and outcomes of patients hospitalized for inflammatory bowel disease. Clin Gastroenterol Hepatol 12(11):1897–1904.e1891CrossRefPubMedGoogle Scholar
  11. 11.
    Malhotra A, Mandip KC, Shaukat A, Rector T (2016) All-cause hospitalizations for inflammatory bowel diseases: can the reason for admission provide information on inpatient resource use? A study from a large veteran affairs hospital. Mil Med Res 3(1):28CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Jung YS, Yoon JY, Lee JH, Jeon SM, Hong SP, Kim TI, Kim WH, Cheon JH (2011) Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Behcet’s disease. Inflamm Bowel Dis 17(7):1594–1602CrossRefPubMedGoogle Scholar
  13. 13.
    Cheon JH, Han DS, Park JY, Ye BD, Jung SA, Park YS, Kim YS, Kim JS, Nam CM, Kim YN, Yang SK, Kim WH (2011) Development, validation, and responsiveness of a novel disease activity index for intestinal Behcet’s disease. Inflamm Bowel Dis 17(2):605–613CrossRefPubMedGoogle Scholar
  14. 14.
    Jung YS, Cheon JH, Park SJ, Hong SP, Kim TI, Kim WH (2013) Clinical course of intestinal Behcet’s disease during the first five years. Dig Dis Sci 58(2):496–503CrossRefPubMedGoogle Scholar
  15. 15.
    Baek SJ, Kim CW, Cho MS, Jang HA, Baik SH, Hur H, Min BS, Kim NK (2015) Surgical treatment and outcomes in patients with intestinal Behcet disease: long-term experience of a single large-volume center. Dis Colon Rectum 58(6):575–581CrossRefPubMedGoogle Scholar
  16. 16.
    Allegretti JR, Borges L, Lucci M, Chang M, Cao B, Collins E, Vogel B, Arthur E, Emmons D, Korzenik JR (2015) Risk factors for rehospitalization within 90 days in patients with inflammatory bowel disease. Inflamm Bowel Dis 21(11):2583–2589CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Hazratjee N, Agito M, Lopez R, Lashner B, Rizk MK (2013) Hospital readmissions in patients with inflammatory bowel disease. Am J Gastroenterol 108(7):1024–1032CrossRefPubMedGoogle Scholar
  18. 18.
    Hisamatsu T, Hayashida M (2017) Treatment and outcomes: medical and surgical treatment for intestinal Behcet’s disease. Intest Res 15(3):318–327CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International League of Associations for Rheumatology (ILAR) 2017

Authors and Affiliations

  • Yong Eun Park
    • 1
  • Jae Hee Cheon
    • 1
    • 2
    Email author
  • Yehyun Park
    • 1
    • 2
  • Soo Jung Park
    • 1
    • 2
  • Tae Il Kim
    • 1
    • 2
  • Won Ho Kim
    • 1
    • 2
  1. 1.Department of Internal Medicine, College of MedicineYonsei UniversitySeoulSouth Korea
  2. 2.Institute of Gastroenterology, College of MedicineYonsei UniversitySeoulSouth Korea

Personalised recommendations